Here is the honest version
Jul 16, 2026 FDA Publishes All 7 Briefing Documents Ahead of the July 2026 PCAC Meeting The FDA has posted all seven scientific briefing documents for the July 2324, 2026 Pharmacy Compounding Advisory Committee meeting an unusually clear window into the agency's current thinking on peptide safety, efficacy, and characterization
What's Included Tirzepatide activates both GLP-1 and GIP receptors for stronger appetite control, improved insulin sensitivity, and greater average weight loss in clinical trials
PlexusDx provides compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, plus oral semaglutide, tirzepatide, dual-compound options, and the Precision Peptide Genetic Test to map your peptide-pathway genetics across 49 peptides and 14 pathways